Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Wolthers, SA, Stenberg, J, Nielsen, HB, Stensballe, J & Pedersen, HP 2021, 'Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19', Ugeskrift for Laeger, bind 183, nr. 35.

APA

Wolthers, S. A., Stenberg, J., Nielsen, H. B., Stensballe, J., & Pedersen, H. P. (2021). Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19. Ugeskrift for Laeger, 183(35).

CBE

MLA

Vancouver

Wolthers SA, Stenberg J, Nielsen HB, Stensballe J, Pedersen HP. Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19. Ugeskrift for Laeger. 2021 aug 30;183(35).

Author

Wolthers, Signe Amalie ; Stenberg, Jakob ; Nielsen, Henning Bay ; Stensballe, Jakob ; Pedersen, Henrik Planck. / Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19. I: Ugeskrift for Laeger. 2021 ; Bind 183, Nr. 35.

Bibtex

@article{0774720f33b74f589eb73288f8a7d1ba,
title = "Intracerebral h{\ae}moragi tolv dage efter vaccination med ChAdOx1 nCoV-19",
abstract = "The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.",
keywords = "COVID-19, COVID-19 Vaccines, Cerebral Hemorrhage, Humans, Male, SARS-CoV-2, Vaccination",
author = "Wolthers, {Signe Amalie} and Jakob Stenberg and Nielsen, {Henning Bay} and Jakob Stensballe and Pedersen, {Henrik Planck}",
year = "2021",
month = aug,
day = "30",
language = "Dansk",
volume = "183",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "35",

}

RIS

TY - JOUR

T1 - Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19

AU - Wolthers, Signe Amalie

AU - Stenberg, Jakob

AU - Nielsen, Henning Bay

AU - Stensballe, Jakob

AU - Pedersen, Henrik Planck

PY - 2021/8/30

Y1 - 2021/8/30

N2 - The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.

AB - The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.

KW - COVID-19

KW - COVID-19 Vaccines

KW - Cerebral Hemorrhage

KW - Humans

KW - Male

KW - SARS-CoV-2

KW - Vaccination

M3 - Tidsskriftartikel

C2 - 34477089

VL - 183

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 35

ER -

ID: 67622566